Argenx Se ARGX
NASDAQ ARGX
$1,038.85 -14.61 (-1.39%)
As of: Sep 4, 2026 · 10:51 AM EDT

Argenx Se (ARGX) Shares Outstanding (2015 - 2026)

Argenx Se's (ARGX) quarterly Shares Outstanding (Entity) came in at $147.7 million in Q2 2026, up 1.89% YoY from $145.0 million in Q2 2025, and little changed on a QoQ basis from $147.4 million in Q1 2026.

Analysis

Argenx Se (ARGX) Shares Outstanding (2015 - 2026) Analysis & Trends

Argenx Se (ARGX) has 12 years of Shares Outstanding (Entity) data on file, last reported at $147.7 million in Q2 2026.

  • Quarterly Shares Outstanding (Entity) rose 1.89% year-over-year to $147.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $147.7 million (up 1.89% YoY) and the FY2025 annual result came in at $145.6 million, up 2.41% from the prior year.
  • Shares Outstanding (Entity) steadied at $147.7 million in Q2 2026, from $147.4 million in the prior quarter.
  • In the past five years, Shares Outstanding (Entity) ranged from a high of $147.7 million in Q2 2026 to a low of $123.7 million in Q1 2022.
  • A 5-year average of $138.4 million and a median of $141.0 million in 2024 frame the typical range for Shares Outstanding (Entity).
  • Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) rose 7.26% — and 2026, when it grew 1.76%.
  • Tracing ARGX's Shares Outstanding (Entity) over 5 years: stood at $129.2 million in 2022, then rose by 5.13% to $135.8 million in 2023, then rose by 4.7% to $142.2 million in 2024, then gained by 2.41% to $145.6 million in 2025, then gained by 1.45% to $147.7 million in 2026.
  • The last three Shares Outstanding (Entity) figures came in at $147.7 million (Q2 2026), $147.4 million (Q1 2026), and $145.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 139.68 Bn 131.82 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.68 Bn 77.68 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 63.67 Bn 58.48 Bn 1.37 Bn 61.30 Mn
4 Moderna 57.02 Bn 51.88 Bn 52.00 Mn 398.00 Mn
5 Revolution Medicines 43.83 Bn 43.83 Bn - 210.89 Mn
6 BeOne Medicines 39.97 Bn 34.87 Bn 1.53 Bn 111.58 Mn
7 Alnylam Pharmaceuticals 35.23 Bn 31.93 Bn 992.69 Mn 133.61 Mn
8 Royalty Pharma 28.56 Bn 27.72 Bn - 445.06 Mn
9 Insmed 27.54 Bn 26.38 Bn 358.27 Mn 217.35 Mn
10 Incyte 25.49 Bn 20.95 Bn 1.57 Bn 200.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 61.30 Mn
Mar 31, 2026 61.30 Mn
Dec 31, 2025 61.30 Mn
Sep 30, 2025 59.86 Mn
Jun 30, 2025 59.86 Mn
Mar 31, 2025 59.86 Mn
Dec 31, 2024 59.86 Mn
Sep 30, 2024 57.17 Mn
Jun 30, 2024 57.17 Mn
Mar 31, 2024 57.17 Mn
Dec 31, 2023 57.17 Mn
Sep 30, 2023 54.38 Mn
Jun 30, 2023 54.38 Mn
Mar 31, 2023 54.38 Mn
Dec 31, 2022 54.38 Mn
Sep 30, 2022 51.08 Mn
Jun 30, 2022 51.08 Mn
Mar 31, 2022 51.08 Mn
Dec 31, 2021 51.08 Mn
Sep 30, 2021 45.41 Mn